What is Collegium Pharmaceutical Price-to-Operating-Cash-Flow?
As of today (2024-06-11), Collegium Pharmaceutical's share price is €30.40.
Collegium Pharmaceutical's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2024 was €6.26. Hence, Collegium Pharmaceutical's Price-to-Operating-Cash-Flow Ratio for today is 4.85.
The historical rank and industry rank for Collegium Pharmaceutical's Price-to-Operating-Cash-Flow or its related term are showing as below:
STU:354'
s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 2.8 Med: 7.33 Max: 30.81
Current: 4.92
During the past 11 years, Collegium Pharmaceutical's highest Price-to-Operating-Cash-Flow Ratio was 30.81. The lowest was 2.80. And the median was 7.33.
Collegium Pharmaceutical's Cash Flow from Operations per share for the
three
months ended in Mar. 2024 was €1.38.
Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2024 was €6.26.
During the past 12 months, the average Operating Cash Flow per Share Growth Rate of Collegium Pharmaceutical was 30.00% per year.
During the past 3 years, the average Operating Cash Flow per Share Growth Rate was 35.00% per year.
During the past 5 years, the average Operating Cash Flow per Share Growth Rate was 17.50% per year.
During the past 11 years, Collegium Pharmaceutical's highest 3-Year average Operating Cash Flow per Share Growth Rate was 64.20% per year. The lowest was -21.10% per year. And the median was 2.70% per year.
Collegium Pharmaceutical Price-to-Operating-Cash-Flow Historical Data
The historical data trend for Collegium Pharmaceutical's Price-to-Operating-Cash-Flow can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Collegium Pharmaceutical Price-to-Operating-Cash-Flow Chart
|
Collegium Pharmaceutical Annual Data
|
|
Trend |
Dec14 |
Dec15 |
Dec16 |
Dec17 |
Dec18 |
Dec19 |
Dec20 |
Dec21 |
Dec22 |
Dec23 |
| Price-to-Operating-Cash-Flow |
|
Get a 7-Day Free Trial
|
|
|
24.80 |
7.49 |
7.40 |
6.32 |
4.68 |
|
Collegium Pharmaceutical Quarterly Data
|
|
Jun19 |
Sep19 |
Dec19 |
Mar20 |
Jun20 |
Sep20 |
Dec20 |
Mar21 |
Jun21 |
Sep21 |
Dec21 |
Mar22 |
Jun22 |
Sep22 |
Dec22 |
Mar23 |
Jun23 |
Sep23 |
Dec23 |
Mar24 |
| Price-to-Operating-Cash-Flow |
Get a 7-Day Free Trial
|
|
|
|
|
|
|
|
|
|
|
|
|
4.61 |
3.39 |
3.25 |
4.68 |
5.73 |
Competitive Comparison of Collegium Pharmaceutical's Price-to-Operating-Cash-Flow
For the Drug Manufacturers - Specialty & Generic subindustry, Collegium Pharmaceutical's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Collegium Pharmaceutical's Price-to-Operating-Cash-Flow Distribution in the Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Collegium Pharmaceutical's Price-to-Operating-Cash-Flow distribution charts can be found below:
* The bar in red indicates where Collegium Pharmaceutical's Price-to-Operating-Cash-Flow falls into.
Collegium Pharmaceutical Price-to-Operating-Cash-Flow Calculation
Collegium Pharmaceutical's Price-to-Operating-Cash-Flow ratio for today is calculated as
| Price-to-Operating-Cash-Flow Ratio | = | Share Price | / | Cash Flow from Operations per share (TTM) |
| = | 30.40 | / | 6.262 |
| = | 4.85 |
Collegium Pharmaceutical's Share Price of today is €30.40.
Collegium Pharmaceutical's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €6.26.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).
It can also be calculated from the numbers for the whole company:
Collegium Pharmaceutical (STU:354) Business Description
Traded in Other Exchanges
Address
100 Technology Center Drive, Stoughton, MA, USA, 02072
Collegium Pharmaceutical Inc is a specialty pharmaceutical company. The company is engaged in developing and planning to commercialize abuse-deterrent products that incorporate its patented DETERx platform technology for the treatment of chronic pain and other diseases. The DETERx platform technology is designed to maintain the extended-release and safety profiles of highly abused drugs in the face of various methods including chewing, crushing, and dissolving. Its product portfolio includes Xtampza ER, which is an abuse-deterrent, extended-release, oral formulation of oxycodone; and Nucynta Products, which are extended-release & immediate-release formulations of tapentadol.
Collegium Pharmaceutical (STU:354) Headlines
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
STU:354 has been successfully added to your